Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: a joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology.

Steeds, Richard P; Stiles, Craig E; Sharma, Vishal; Chambers, John B; Lloyd, Guy; Drake, William

Steeds, Richard P; Stiles, Craig E; Sharma, Vishal; Chambers, John B; Lloyd, Guy; Drake, William.

Afiliación

Steeds RP; University Hospital Birmingham, Birmingham, UK.
Stiles CE; Institute of Cardiology, University of Birmingham, Birmingham, UK.
Sharma V; Department of Endocrinology, Saint Bartholomew's Hospital, London, UK.
Chambers JB; Department of Cardiology, Royal Liverpool and Broadgreen University Hospital, Liverpool, UK.
Lloyd G; Cardiothoracic Centre, Guy's and St Thomas' Hospitals - London, UK.
Drake W; Department of Cardiology, Saint Bartholomew's Hospital, London, UK.

Echo Res Pract ; 6(1): G1-G8, 2019 Mar 01.

Article en En | MEDLINE | ID: mdl-30825409

Palabras clave

dopamine agonist; hyperprolactinaemia; monitoring; transthoracic echocardiography; valve disease

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Echo Res Pract Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google